aid: rgenta-therapeutics name: Rgenta Therapeutics description: >- Rgenta Therapeutics is a clinical-stage biotechnology company headquartered at 300 TradeCenter, Woburn, Massachusetts, developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Its discovery platform mines large-scale genomics data to identify targetable RNA processing events, then designs small molecules that modulate the interactions among the spliceosome, RNA-binding regulatory proteins and RNA itself in order to shut down production of disease-driving proteins previously considered undruggable. Its lead clinical asset, RGT-61159, is an orally available modulator of MYB splicing in development for adenoid cystic carcinoma and colorectal cancer, and its RSwitch technology applies the same chemistry to tune transgene expression in AAV-delivered gene and cell therapies. Rgenta is a therapeutics developer, not a software vendor: it publishes no API, no developer portal and no machine-readable API contract of any kind. deliveryModel: model: unknown open_source: false commercial: false callable_host: false label: Delivery model not determined — needs a product licence on record confidence: low source: - none generated: '2026-08-28' method: derived image: https://kinlane-productions2.s3.amazonaws.com/apis-json/apis-json-logo.jpg url: https://raw.githubusercontent.com/api-evangelist/rgenta-therapeutics/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: stub x-tier-reason: harvest specificationVersion: '0.20' created: '2026-08-26' modified: '2026-08-26' tags: - Company - Biotechnology - Pharmaceuticals - Life Sciences - Drug Discovery - Oncology - RNA Therapeutics - Healthcare apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/rgenta-therapeutics-domain-security.yml - type: Website url: https://www.rgentatx.com/ - type: About url: https://www.rgentatx.com/about-us - type: Blog url: https://www.rgentatx.com/news - type: PrivacyPolicy url: https://www.rgentatx.com/privacy-policy - type: Contact url: https://www.rgentatx.com/contact - type: Careers url: https://www.rgentatx.com/careers - type: LinkedIn url: https://www.linkedin.com/company/rgenta-therapeutics-inc/ - type: LLMsTxt url: llms/rgenta-therapeutics-llms.txt x-enrichment: date: '2026-08-26' status: minimal artifacts_added: 4 pass: local-v1 x-coverage: state: none reason: not-a-software-company detail: >- Rgenta Therapeutics is a clinical-stage drug developer whose product is a molecule, not software; its single public host is a Wix marketing site whose own llms.txt enumerates all eleven pages it serves and none of them is a developer, API or data page. evidence: - url: https://www.rgentatx.com/llms.txt status: 200 - url: https://www.rgentatx.com/openapi.json status: 404 - url: https://www.rgentatx.com/.well-known/agent-card.json status: 404 - url: https://www.rgentatx.com/graphql status: 404 checked: '2026-08-26'